GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (OTCPK:MDGEF) » Definitions » 14-Day RSI

MDGEF (Medigene AG) 14-Day RSI : 24.09 (As of Dec. 16, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medigene AG 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-16), Medigene AG's 14-Day RSI is 24.09.

The industry rank for Medigene AG's 14-Day RSI or its related term are showing as below:

MDGEF's 14-Day RSI is ranked better than
81.81% of 1523 companies
in the Biotechnology industry
Industry Median: 44.97 vs MDGEF: 24.09

Competitive Comparison of Medigene AG's 14-Day RSI

For the Biotechnology subindustry, Medigene AG's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigene AG's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Medigene AG's 14-Day RSI falls into.



Medigene AG  (OTCPK:MDGEF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medigene AG  (OTCPK:MDGEF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Medigene AG 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Medigene AG's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigene AG Business Description

Traded in Other Exchanges
Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG Headlines

From GuruFocus

Q4 2022 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 Medigene AG Earnings Call Transcript

By GuruFocus Research 08-15-2024

Q2 2022 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024